AS

Anshul Singh

Active Director Director DIN 08837781
DIN 08837781 First appointment Aug 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Anshul Singh

Data last updated:

Anshul Singh is a Director at Styron Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Styron Pharmaceuticals Private Limited reported revenue of ₹31.3 Lakh (FY 2025).

DIN 08837781
Primary Designation Director
Industry Chemicals
First Appointment 18 Aug 2020
Oldest Company Age 6 yrs
Largest company Styron Pharmaceuticals Private Limited · ₹31.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20202020₹31.3 Lakh (FY 2025)Active

Board colleagues of Anshul Singh

NameDINCompanyDesignation
Rishabh Sharma08837843Styron Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Styron Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anshul Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anshul Singh

Anshul Singh currently holds 1 directorship: Styron Pharmaceuticals Private Limited (Director, since 18 Aug 2020, revenue ₹31.3 Lakh (FY 2025)).

Anshul Singh was first appointed on 18 Aug 2020 as Director at Styron Pharmaceuticals Private Limited.

The current boards of Anshul Singh's companies include Rishabh Sharma (Styron Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available